NFL BIOSCIENCES: PRE-IND APPLICATION FILED WITH THE FDA IN THE UNITED STATES FOR NFL-301, INDICATED FOR REDUCING ALCOHOL CONSUMPTION

19 Dec 2023 08:00 CET

Subscribe
Issuer

NFL BIOSCIENCES S.A.

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

Appendix

Source

NFL BIOSCIENCES

Provider

Les Echos

Company Name

NFL BIOSCIENCES S.A.

ISIN

FR0014003XT0

Symbol

ALNFL

Market

Euronext Growth

Attachments

Disclaimer

NFL Biosciences SA published this content on 19 December 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 December 2023 07:07:31 UTC.